International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer

Journal of the National Cancer Institute

Volumn 104, Issue 24, 2012, Pages 1888-1896

  Meretoja, Tuomo J ^a   Leidenius, Marjut H K ^a   Heikkilä, Päivi S ^b   Boross, Gabor ^a   Sejben, István ^b   Regitnig, Peter ^b,c   Luschin Ebengreuth, Gero ^b   Žgajnar, Janez ^b,d   Perhavec, Andraz ^b,d   Gazic, Barbara ^b   Lázár, György ^e   Takács, Tibor ^e   Vörös, Andras ^b   Saidan, Zuhair A ^f,g   Nadeem, Rana M ^f,g   Castellano, Isabella ^h   Sapino, Anna ^h   Bianchi, Simonetta ⁱ   Vezzosi, Vania ⁱ   Barranger, Emmanuel ^j   Lousquy, Ruben ^j   Arisio, Riccardo ^k   Foschini, Maria Pia ^l   Imoto, Shigeru ^b   Kamma, Hiroshi ^b   Tvedskov, Tove F ^b,m   Kroman, Niels ^b,m   Jensen, Maj Brit ⁿ   Audisio, Riccardo A ^o,p   Cserni, Gabor ^b   more..

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Department of Pathology ^*  (Japan)

^c BÁCS KISKUN COUNTY TEACHING HOSPITAL   (Hungary)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e INSTITUTE OF ONCOLOGY   (Slovenia)

^f UNIVERSITY OF SZEGED   (Hungary)

^g LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^h UNIVERSITY OF TURIN   (Italy)

ⁱ UNIVERSITY OF FLORENCE   (Italy)

^j HÔPITAL LARIBOISIÈRE   (France)

^k Sant'Anna OIRM Hospital   (Italy)

^l UNIVERSITY OF BOLOGNA   (Italy)

^m KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ Danish Breast Cancer Cooperative Group   (Denmark)

^o Mental Health Center Glostrup   (Denmark)

^p St Helens Teaching Hospital   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AXILLARY LYMPH NODE EXTIRPATION; BREAST CANCER; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; STATISTICAL ANALYSIS;

ADULT; AGED; ANALYSIS OF VARIANCE; AREA UNDER CURVE; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CONFOUNDING FACTORS (EPIDEMIOLOGY); EUROPE; FEMALE; FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERNATIONAL COOPERATION; LOGISTIC MODELS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SENTINEL LYMPH NODE BIOPSY;

EID: 84871840748     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs455     Document Type: Article

References (32)

1. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003;10(10):1140-1151.
2. Hwang RF, Krishnamurthy S, Hunt KK, et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol. 2003;10(3):248-254.
3. Farshid G, Pradhan M, Kollias J, Gill PG. A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node. Breast. 2004;13(6):494-501.
4. Saidi RF, Dudrick PS, Remine SG, Mittal VK. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer. Am Surg. 2004;70(2):101-105; discussion 105.
5. Barranger E, Coutant C, Flahault A, Delpech Y, Darai E, Uzan S. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat. 2005;91(2):113-119.
6. Degnim AC, Reynolds C, Pantvaidya G, et al. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg. 2005;190(4):543-550.
7. Chagpar AB, Scoggins CR, Martin RC, et al. Prediction of sentinel lymph node-only disease in women with invasive breast cancer. Am J Surg. 2006;192(6):882-887.
8. Pal A, Provenzano E, Duffy SW, Pinder SE, Purushotham AD. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg. 2008;95(3):302-309.
9. Houvenaeghel G, Nos C, Giard S, et al. A nomogram predictive of nonsentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur J Surg Oncol. 2009;35(7):690-695.
10. Kohrt HE, Olshen RA, Bermas HR, et al. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer. 2008;8:66.
11. Cho J, Han W, Lee JW, et al. A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring systems. Ann Surg Oncol. 2008;15(8):2278-2286.
12. Gur AS, Unal B, Ozbek U, et al. Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study. Eur J Surg Oncol. 2010;36(1):30-35.
13. Perhavec A, Perme MP, Hocevar M, Besi? N, Zgajnar J. Ljubljana nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node. Breast Cancer Res Treat. 2010;119(2):357-366.
14. Coufal O, Pavlík T, Fabian P, et al. Predicting non-sentinel lymph node status after positive sentinel biopsy in breast cancer: what model performs the best in a Czech population? Pathol Oncol Res. 2009;15(4):733-740.
15. Meretoja TJ, Strien L, Heikkilä PS, Leidenius MH. A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement. Ann Surg Oncol. 2012;19(2):567-576.
16. Tvedskov TF, Jensen MB, Lisse IM, Ejlertsen B, Balslev E, Kroman N. High risk of non-sentinel node metastases in a group of breast cancer patients with micrometastases in the sentinel node. Int J Cancer. 2012;131(10):2367-2375.
17. Galimberti V, Cole B, Zurrida S, et al. Update of International Breast Cancer Study Group trial 23-01 to compare axillary dissection versus no axillary dissection in patients with clinically node negative breast cancer and micrometastases in the sentinel node. Paper presented at San Antonio Breast Cancer Symposium; December 2011; San Antonio, TX.
18. Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252(3):426-432; discussion 432-433.
19. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569-575.
20. Pepels MJ, de Boer M, Bult P, et al. Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells. Ann Surg. 2012;255(1):116-121.
21. Cserni G, Bori R, Maráz R, et al. Multi-Institutional comparison of nonsentinel lymph node predictive tools in breast cancer patients with high predicted risk of further axillary metastasis [published online ahead of print July 14, 2012]. Pathol Oncol Res. 2012;doi: 10.1007/s12253-012-9553-5.
22. Cserni G, Boross G, Maráz R, et al. Multicentre validation of different predictive tools of non-sentinel lymph node involvement in breast cancer. Surg Oncol. 2012;21(2):59-65.
23. Sobin LH, Wittekind Ch, eds. TNM Classification of Malignant Tumours. 6th ed. New York: Wiley-Liss; 2002.
24. Coutant C, Olivier C, Lambaudie E, et al. Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol. 2009;27(17):2800-2808.
25. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987;235(4785):177-182.
26. Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003;100(14):8418-8423.
27. Van Calster B, Vanden Bempt I, Drijkoningen M, et al. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive. Breast Cancer Res Treat. 2009;113(1):181-187.
28. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006;106(1):4-16.
29. van Wely BJ, Teerenstra S, Schinagl DA, Aufenacker TJ, de Wilt JH, Strobbe LJ. Systematic review of the effect of external beam radiation therapy to the breast on axillary recurrence after negative sentinel lymph node biopsy. Br J Surg. 2011;98(3):326-333.
30. Meretoja TJ, Leidenius MH, Heikkila PS, Joensuu H. Sentinel node biopsy in breast cancer patients with large or multifocal tumors. Ann Surg Oncol. 2009;16(5):1148-1155.
31. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087-2106.
32. Straver ME, Meijnen P, van Tienhoven G, et al. Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol. 2010;28(5):731-737.